| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.035 | 0.9 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.9 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |